Whalesbook
What Happened
Swara Baby Products, a manufacturer specializing in disposable hygiene items, is planning to file its draft documents for an Initial Public Offering (IPO) this month. The company aims to raise up to ₹1,000 crore through this public issue. The offering is expected to include a mix of fresh equity issuance and an offer for sale (OFS) by current shareholders. The company has appointed JM Financial and Avendus Capital to manage the IPO process.
Understanding the Business Model
It is important for investors to understand that Swara Baby operates primarily as an outsourced manufacturing partner for global consumer giants. Rather than focusing solely on building its own retail brand, the company produces diapers, sanitary napkins, and incontinence products for major corporations including Unicharm, Procter & Gamble, Kimberly-Clark, and Kenvue. This business model relies on large-scale manufacturing to achieve efficiency. Since its inception in 2021, the company has grown from a single-product manufacturer to one with seven distinct categories, supported by four manufacturing facilities in Madhya Pradesh.
Financial Snapshot
The company has demonstrated rapid financial growth, reporting a compound annual growth rate (CAGR) of over 30% between fiscal years 2023 and 2025. According to disclosures, the company’s revenue reached ₹943 crore in FY25, compared to ₹545 crore in FY23. Profit after tax also grew, climbing to ₹81 crore from ₹26 crore in the same period. These figures reflect a business that has scaled production quickly to meet the demands of its large corporate partners.
The Risk of Client Concentration
While the association with global brands like Procter & Gamble and Kimberly-Clark provides stable demand, it also creates a unique risk profile for investors. As a contract manufacturer, the company’s profitability is often tied to the volume requirements and pricing terms set by these large multinational clients. If one of these major partners decides to shift its manufacturing strategy or change suppliers, it could materially impact Swara Baby’s revenue. Additionally, as a manufacturer of commodity-linked hygiene products, the company is susceptible to fluctuations in raw material prices, such as wood pulp and polymers. Investors should analyze whether the company can maintain its profit margins if raw material costs rise sharply.
Strategic Expansion
Swara Baby has been actively expanding its capabilities through acquisitions, such as the purchase of KA Hygiene and Solis Hygiene in December 2025. The company has also established an international trading entity in the US. These moves suggest that the company is trying to diversify its operational footprint and potentially enter new markets. When reviewing the IPO filing, investors may want to check how these acquisitions are contributing to total earnings and whether they have added debt to the company’s balance sheet.
What Investors Should Track Next
When the draft papers are released, there are several key areas for investors to monitor. First, the specific breakdown of the use of funds will be crucial; investors will want to know if the money is intended for debt reduction, capacity expansion, or working capital. Second, the filing will likely disclose the degree of client concentration, revealing exactly how much revenue is tied to its top two or three customers. Finally, management's commentary on how they plan to manage input cost volatility will be important, as this often dictates the sustainability of margins in the hygiene manufacturing sector.